{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:21:00Z","timestamp":1787314860495,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul University","doi-asserted-by":"publisher","award":["T-20867"],"award-info":[{"award-number":["T-20867"]}],"id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bmc.2019.115130","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T12:10:05Z","timestamp":1573215005000},"page":"115130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones"],"prefix":"10.1016","volume":"28","author":[{"given":"G\u00f6k\u00e7e","family":"Cihan-\u00dcst\u00fcnda\u011f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet","family":"Zopun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Vanderlinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Ozkirimli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leentje","family":"Persoons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcltaze","family":"\u00c7apan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.115130_b0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMp1400034","article-title":"Preventing and controlling influenza with available interventions","volume":"370","author":"Uyeki","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2019.115130_b0010","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2019.115130_b0015","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMcp1512870","article-title":"Clinical practice. Influenza vaccination","volume":"375","author":"Treanor","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2019.115130_b0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/cid\/ciy097","article-title":"Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012\u201313","volume":"67","author":"Cobey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2019.115130_b0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12879-017-2432-7","article-title":"Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1","volume":"17","author":"Kwok","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bmc.2019.115130_b0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2014.11.020","article-title":"Neuraminidase inhibitors: Who, when, where?","volume":"21","author":"Nguyen-Van-Tam","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bmc.2019.115130_b0035","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMp0900648","article-title":"Global transmission of oseltamivir-resistant influenza","volume":"360","author":"Moscona","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2019.115130_b0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.coph.2016.08.003","article-title":"Antiviral therapies on the horizon for influenza","volume":"30","author":"Naesens","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bmc.2019.115130_b0045","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/med.21401","article-title":"The influenza virus polymerase complex: An update on its structure, functions, and significance for antiviral drug design","volume":"36","author":"Stevaert","year":"2016","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2019.115130_b0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.antiviral.2016.06.007","article-title":"Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir","volume":"132","author":"Takashita","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2019.115130_b0055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil investigators G. Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2019.115130_b0060","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/ijms18071541","article-title":"The interplay between the host receptor and influenza virus hemagglutinin and neuraminidase","volume":"18","author":"Byrd-Leotis","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2019.115130_b0065","first-page":"93","article-title":"Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology","volume":"385","author":"Russell","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.bmc.2019.115130_b0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza A virus: Host factors and antiviral targets","volume":"95","author":"Edinger","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bmc.2019.115130_b0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/med.21289","article-title":"Emerging antiviral strategies to interfere with influenza virus entry","volume":"34","author":"Vanderlinden","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2019.115130_b0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2019.115130_b0085","doi-asserted-by":"crossref","first-page":"17736","DOI":"10.1073\/pnas.0807142105","article-title":"Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion","volume":"105","author":"Russell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2019.115130_b0090","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/JVI.02325-09","article-title":"Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin","volume":"84","author":"Vanderlinden","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.115130_b0095","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1016\/j.bmc.2012.09.064","article-title":"Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives","volume":"20","author":"G\u00f6kta\u015f","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2019.115130_b0100","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/10426507.2014.965819","article-title":"Synthesis and structure-activity relationship of N-(3-oxo-1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide inhibitors of influenza virus hemagglutinin mediated fusion","volume":"190","author":"G\u00f6kta\u015f","year":"2014","journal-title":"Phosphorus, Sulfur, Silicon Related Elements"},{"key":"10.1016\/j.bmc.2019.115130_b0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coviro.2017.03.002","article-title":"Tackling influenza with broadly neutralizing antibodies","volume":"24","author":"Corti","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.bmc.2019.115130_b0110","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar6221","article-title":"A small-molecule fusion inhibitor of influenza virus is orally active in mice","volume":"363","author":"van Dongen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bmc.2019.115130_b0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jmv.25358","article-title":"Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study","volume":"91","author":"Leneva","year":"2019","journal-title":"J Med Virol"},{"key":"10.1016\/j.bmc.2019.115130_b0120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: An update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2019.115130_b0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/acs.jmedchem.7b00908","article-title":"Aniline-based inhibitors of influenza H1N1 virus acting on hemagglutinin-mediated fusion","volume":"61","author":"Leiva","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115130_b0130","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jps.2600780917","article-title":"Synthesis and antimicrobial activity of new substituted 10-methyl-1,2-dihydro-1-oxo-1,2,4-triazino(4,5-a)indoles","volume":"78","author":"Rajur","year":"1989","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bmc.2019.115130_b0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11030-012-9385-y","article-title":"Synthesis and evaluation of functionalized indoles as antimycobacterial and anticancer agents","volume":"16","author":"Cihan-Ustundag","year":"2012","journal-title":"Mol Diversity"},{"key":"10.1016\/j.bmc.2019.115130_b0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.virol.2007.08.035","article-title":"Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion","volume":"370","author":"Thoennes","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.bmc.2019.115130_b0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(85)90157-6","article-title":"Fusion mutants of the influenza virus hemagglutinin glycoprotein","volume":"40","author":"Daniels","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2019.115130_b0150","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1128\/jvi.71.11.8808-8820.1997","article-title":"Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: Irreversible inhibition of infectivity","volume":"71","author":"Hoffman","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.115130_b0155","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1021\/cr900249z","article-title":"Fluorescent indicators for intracellular pH","volume":"110","author":"Han","year":"2010","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2019.115130_b0160","doi-asserted-by":"crossref","first-page":"17889","DOI":"10.1073\/pnas.1114107108","article-title":"Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase","volume":"108","author":"Snyder","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2019.115130_b0165","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.1801999115","article-title":"A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin","volume":"115","author":"Kadam","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2019.115130_b0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2008.10.009","article-title":"Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol","volume":"81","author":"Leneva","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2019.115130_b0175","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1099\/jgv.0.001235","article-title":"Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor beta signalling pathway","volume":"100","author":"Vrijens","year":"2019","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bmc.2019.115130_b0180","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2019.115130_b0185","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2019.115130_b0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2019.115130_b0195","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.bmc.2005.12.032","article-title":"New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies","volume":"14","author":"Farid","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2019.115130_b0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","article-title":"Use of an induced fit receptor structure in virtual screening","volume":"67","author":"Sherman","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2019.115130_b0205","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619310259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619310259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:05:02Z","timestamp":1760835902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619310259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0968089619310259"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.115130","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.115130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115130"}}